Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuropsychological differences between treatment-resistant and treatment-responsive schizophrenia: a meta-analysis
Edward Millgate, Olga Hide, Stephen M. Lawrie, et al.
Psychological Medicine (2021) Vol. 52, Iss. 1, pp. 1-13
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice
Ofer Agid, Benedicto Crespo‐Facorro, Andrea de Bartolomeis, et al.
European Neuropsychopharmacology (2024) Vol. 84, pp. 35-47
Open Access | Times Cited: 8
Schizophrenia: A developmental disorder with a risk of non-specific but avoidable decline
Robin M. Murray, Emre Bora, Gemma Modinos, et al.
Schizophrenia Research (2022) Vol. 243, pp. 181-186
Closed Access | Times Cited: 30
Cognitive function at first episode in patients subsequently developing treatment-resistant schizophrenia
Juan Manuel Aguirre, Camila Díaz Dellarossa, Daniella Barbagelata, et al.
Schizophrenia Research (2025) Vol. 276, pp. 178-184
Closed Access
Relationship between cognitive impairments and psychopathological symptoms in female schizophrenia subsequent to 8 weeks treatment with antipsychotic drugs
Shuzhan Gao, Qing Xu, Youngwoong Han, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Schizophrenia and Related Psychoses

(2025), pp. 1-278
Closed Access
Treatment-resistant schizophrenia: How far have we traveled?
Ambu Pandey, Kamal Narayan Kalita
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 18
Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration
Alice Egerton, Kira Griffiths, Cecila Casetta, et al.
Neuropsychopharmacology (2022) Vol. 48, Iss. 3, pp. 567-575
Open Access | Times Cited: 17
Role of the immune-kynurenine pathway in treatment-resistant schizophrenia
Wenjin Chen, Yichang Tian, Mengzhuang Gou, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 130, pp. 110926-110926
Open Access | Times Cited: 10
The ever-growing case for clozapine in the treatment of schizophrenia: an obligation for psychiatrists and psychiatry
Robert A. Bittner, Andreas Reif, Mishal Qubad
Current Opinion in Psychiatry (2023) Vol. 36, Iss. 4, pp. 327-336
Open Access | Times Cited: 9
A systematic review and meta-analysis of the effect of clozapine on cognitive functions in patients with treatment-resistant schizophrenia
Natalie Kwok Wing Cheuk, Wing Tse, Harry Kam Hung Tsui, et al.
Schizophrenia Research (2023) Vol. 268, pp. 205-222
Closed Access | Times Cited: 9
Unsupervised Machine Learning Driven Analysis of Verbatims of Treatment-Resistant Schizophrenia Patients Having Followed Avatar Therapy
Alexandre Hudon, Mélissa Beaudoin, Kingsada Phraxayavong, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 5, pp. 801-801
Open Access | Times Cited: 5
Gene expression imputation provides clinical and biological insights into treatment-resistant schizophrenia polygenic risk
L. Prohens, Natàlia Rodríguez, Àlex-González Segura, et al.
Psychiatry Research (2024) Vol. 332, pp. 115722-115722
Open Access | Times Cited: 1
Increased NLRP1 mRNA and Protein Expression Suggests Inflammasome Activation in the Dorsolateral Prefrontal and Medial Orbitofrontal Cortex in Schizophrenia
Ena Španić Popovački, Dora Vogrinc, Heidi R. Fuller, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 302-302
Open Access | Times Cited: 1
Aberrant connectivity in the hippocampus, bilateral insula and temporal poles precedes treatment resistance in first-episode psychosis: a prospective resting-state functional magnetic resonance imaging study with connectivity concordance mapping
Stavros Skouras, Maria-Lisa Kleinert, Edwin Lee, et al.
Brain Communications (2024) Vol. 6, Iss. 3
Open Access | Times Cited: 1
Distinct alterations in probabilistic reversal learning across at-risk mental state, first episode psychosis and persistent schizophrenia
J D Griffin, Kelly Diederen, Joost Haarsma, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Factors associated with cognitive dysfunction in treatment-responsive and -resistant schizophrenia: A pilot cross-sectional study
Yuhei Suzuki, Kenya Watanabe, Keiko Kanno‐Nozaki, et al.
Journal of Psychiatric Research (2024) Vol. 178, pp. 228-235
Closed Access | Times Cited: 1
Elevated serum IGFBP-1 levels correlate with cognitive deficits in treatment-resistant and chronic medicated schizophrenia patients
Haidong Yang, Man Yang, Yuting Zhang, et al.
Cytokine (2024) Vol. 182, pp. 156728-156728
Closed Access | Times Cited: 1
Prevalence of treatment-resistant schizophrenia among people with early psychosis and its clinical and demographic correlates
Mirza Detanac, Chelsey Williams, Milan Dragović, et al.
Australian & New Zealand Journal of Psychiatry (2024) Vol. 58, Iss. 12, pp. 1080-1089
Open Access | Times Cited: 1
Antipsychotic medication in people with intellectual disability and schizophrenia: A 25-year updated systematic review and cross-sectional study
Elsa Courtial, Arnaud Pouchon, Mircea Polosan, et al.
Journal of Psychopharmacology (2024)
Closed Access | Times Cited: 1
Cognitive performance at first episode of psychosis and the relationship with future treatment resistance: Evidence from an international prospective cohort study
Edward Millgate, Sophie Smart, Antonio F. Pardiñas, et al.
Schizophrenia Research (2023) Vol. 255, pp. 173-181
Open Access | Times Cited: 2
Impaired verbal memory function is related to anterior cingulate glutamate levels in schizophrenia: findings from the STRATA study
Kira Griffiths, Alice Egerton, Edward Millgate, et al.
Schizophrenia (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 4
Neuroanatomical comparison of treatment-resistant and treatment-responsive schizophrenia patients using the cloud-based brain magnetic resonance image segmentation and parcellation system: An MRIcloud study
Esra Porgalı Zayman, Mehmet Fatih Erbay
Psychiatry Research Neuroimaging (2024) Vol. 339, pp. 111789-111789
Closed Access
Modeling the effects of treatment resistance and anticholinergic burden on cognitive function domains in patients with schizophrenia
Sherry Kit Wa Chan, Tiffanie Sze Wing Pang, Harry Kam Hung Tsui, et al.
Psychiatry Research (2024) Vol. 337, pp. 115985-115985
Closed Access
Treatment-Resistant Schizophrenia
Stavroula Rakitzi, Polyxeni Georgila
(2024), pp. 13-52
Closed Access
Knowledge domain and trends in treatment-resistant schizophrenia (TRS) research based on CiteSpace bibliometrics analysis
Haipeng Cai, Ruonan Du, Jianyi Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Page 1 - Next Page

Scroll to top